SCA Pharmaceuticals Potassium Phosphate Solution Recall: Lack of Sterility
SCA Pharmaceuticals recalls Potassium Phosphate added to 0.9% Sodium Chloride solution due to lack of sterility assurance. This medication is for prescription use only and may pose infection risks if used.
Recall notice
Lack of sterility assurance
Contact the company
What happened, in plain English
SCA Pharmaceuticals is recalling a specific potassium phosphate solution for prescription use because it lacks sterility assurance. This could lead to infections if the medication is used without proper sterility. Read more at govinfonow.com/recall/41547-sca-pharmaceuticals-potassium-phosphate-solution-recall-lack-of-sterility.
Source Summary by GovInfoNow · govinfonow.com/recall/41547-sca-pharmaceuticals-potassium-phosphate-solution-recall-lack-of-sterility · Updated October 8, 2026 · FDA enforcement record: FDA #D-0977-2017
Cite this page
“SCA Pharmaceuticals Potassium Phosphate Solution Recall: Lack of Sterility.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41547-sca-pharmaceuticals-potassium-phosphate-solution-recall-lack-of-sterility. Based on FDA recall #D-0977-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0977-2017%22&limit=1).
Why it’s dangerous
The solution lacks sterility assurance, meaning it may not be free from harmful microorganisms. This can cause infections if the medication is administered to patients without proper sterilization.
Who’s affected
Prescription patients who received this specific potassium phosphate solution from SCA Pharmaceuticals. Those using the medication for medical purposes are most at risk.
How to tell if you have this one
Check the product label for the specific potassium phosphate solution with 250 mL 0.9% Sodium Chloride, 15 mMol (22 mEq K+) total volume. Look for lot numbers from 20170509 to 20170605 and expiration dates up to July 20, 2017.
- Brand
SCA Pharmaceuticals- Category
Drug
All 4 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
LA, PA, NY, WI
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0976-2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol (14.67 mEq K+) Total Approximate Volume 254 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0840-40; Lot #: 20170509@2, Exp 6/23/2017; 20170524@22, Exp 7/8/2017; 20170602@10, Exp 7/17/2017; 20170609@27, Exp 7/24/2017 | 221 bags |
| D-0977-2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-40; Lot #: 20170509@6, Exp 6/23/2017; 20170519@35, Exp 7/3/2017; 20170523@22, Exp 7/7/2017; 20170525@9, Exp 7/9/2017; 20170605@49, Exp 7/20/2017; 20170605@9, Exp 7/20/2017 | 660 bags |
| D-0978-2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-32; Lot #: 20170602@29, Exp 7/17/2017 | 20 bags |
| D-0979-2017 | Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq K+) Total Approximate Volume 260 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0843-40; Lot #: 20170511@58, Exp 6/25/2017 | 20 bags |
What to do — step by step
Check Product Label
Look for the specific product name, lot numbers, and expiration dates listed in the recall notice.
Where it went and when
Where it was distributed
Distributed in 4 states.
FDA distribution: “LA, PA, NY, WI” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Louisiana, New York, Pennsylvania, Wisconsin.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0977-2017 (June 21, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0977-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.